West Pharmaceutical Services, Inc.
WST
$303.80
-$8.27-2.65%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.96% | 0.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.96% | 0.05% | |||
| Cost of Revenue | 9.46% | -1.80% | |||
| Gross Profit | -2.47% | 3.26% | |||
| SG&A Expenses | -7.44% | 6.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -650.00% | 33.33% | |||
| Total Operating Expenses | 4.88% | 0.32% | |||
| Operating Income | 5.22% | -0.91% | |||
| Income Before Tax | 10.94% | -4.94% | |||
| Income Tax Expenses | 34.23% | -2.06% | |||
| Earnings from Continuing Operations | 5.07% | -5.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.07% | -5.64% | |||
| EBIT | 5.22% | -0.91% | |||
| EBITDA | 3.30% | 1.10% | |||
| EPS Basic | 5.51% | -5.78% | |||
| Normalized Basic EPS | 4.52% | 0.81% | |||
| EPS Diluted | 5.49% | -5.21% | |||
| Normalized Diluted EPS | 4.51% | 0.81% | |||
| Average Basic Shares Outstanding | -0.41% | 0.14% | |||
| Average Diluted Shares Outstanding | -0.41% | 0.14% | |||
| Dividend Per Share | 0.00% | 4.76% | |||
| Payout Ratio | -0.05% | 0.11% | |||